Live from the NIH registry
Studies recruiting near Memphis right now
Top 25 of 590 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Germantown, Tennessee (9.0 mi)
· Sponsor: Medtronic
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Complex Congenital Heart Defect, Dysfunctional RVOT Conduit
N/A
Interventional 108 participants sought
LeBonheur Children's Hopsital — Memphis, Tennessee (5.5 mi)
· Sponsor: Edwards Lifesciences
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Saint Jude Children's Research Hospital (Pediatrics only) — Memphis, Tennessee (5.5 mi)
· Sponsor: Pierre Fabre Medicament
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Charles Retina Institute — Germantown, Tennessee (9.0 mi)
· Sponsor: Genentech, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Duplicate_Memphis VA Medical Center /ID# 263250 — Memphis, Tennessee (5.5 mi)
· Sponsor: AbbVie
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Intracranial Aneurysm
N/A
Observational 118 participants sought
Semmes Murphey Clinic/Semmes Murphy Foundation — Memphis, Tennessee (5.5 mi)
· Sponsor: Medtronic Neurovascular Clinical Affairs
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Memphis, Tennessee (5.5 mi)
· Sponsor: Sameek Roychowdhury
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Stern Cardiovascular — Southaven, Mississippi (8.7 mi)
· Sponsor: Duke University
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
The West Clinic, PLLC dba West Cancer Center — Germantown, Tennessee (9.0 mi)
· Sponsor: Pfizer
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 Mutation, Low-grade Glioma
Phase 2
Interventional 96 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: University of California, San Francisco
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Memphis, Tennessee (5.5 mi)
· Sponsor: Daiichi Sankyo
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Clinical Neuroscience Solutions, Inc - Memphis — Memphis, Tennessee (5.5 mi)
· Sponsor: Ardelyx
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
West Cancer Center — Germantown, Tennessee (9.0 mi)
· Sponsor: Immuneering Corporation
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Low-Risk, Early Stage Breast Cancer
N/A
Interventional 400 participants sought
The West Clinic, PC dba West Cancer Center — Germantown, Tennessee (9.0 mi)
· Sponsor: IceCure Medical Ltd.
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
HIV Infection
Phase 1, Phase 2
Interventional 1,120 participants sought
6501, St Jude Children's Research Hospital Clinical Research Site — Memphis, Tennessee (5.5 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
West Cancer Center and Research Institute ( Site 0055) — Germantown, Tennessee (9.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Methodist Le Bonheur Healthcare — Memphis, Tennessee (5.5 mi)
· Sponsor: Novartis Pharmaceuticals
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Semmes Murphey Foundation — Memphis, Tennessee (5.5 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
West Cancer Center — Germantown, Tennessee (9.0 mi)
· Sponsor: Hoffmann-La Roche
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
The West Clinic, PLLC dba West Cancer Center — Germantown, Tennessee (9.0 mi)
· Sponsor: Pfizer
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: St. Jude Children's Research Hospital
Functional Ovarian Reserve in Sickle Cell Disease
Sickle Cell Disease
N/A
Observational 440 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: St. Jude Children's Research Hospital
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3
Interventional 562 participants sought
Baptist Memorial Hospital and Cancer Center-Memphis — Memphis, Tennessee (5.5 mi)
· Sponsor: SWOG Cancer Research Network
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Transthyretin Amyloid Cardiomyopathy
N/A
Observational 500 participants sought
Research Site — Germantown, Tennessee (9.0 mi)
· Sponsor: AstraZeneca
A Study of MZE782 in Adults With PKU
Phenylketonuria (PKU)
Phase 2
Interventional 38 participants sought
University of Tennessee Health Science Center Le Bonheur Children's Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: Maze Therapeutics